Moreover, in vivo studies using transplants of paclitaxel-resistant cells have demonstrated that silencing FTH1P3 leads to diminished ABCB1 protein levels and curtailed tumor growth, highlighting its direct influence on the miR-206/ABCB1 signaling pathway. This evidence concerns the gene ABCB1 and neoplasm.